Moderna Inc. Stock Rallies 4.4%, Outperforms Competitors

Dow Jones
2025/06/25

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Moderna Inc. rose 4.4% to $26.80 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 1.4% to 19,912.53 and the Dow Jones Industrial Average rising 1.2% to 43,089.02.

Moderna Inc. closed 80.6% short of its 52-week high of $138.07, which the company reached on June 25th.

The stock outperformed some of its competitors, as Johnson & Johnson rose 0.6% to $152.19, Pfizer Inc. rose 1.2% to $24.31, and Gilead Sciences Inc. rose 0.95% to $107.20.

Trading volume totaled 8.0 million, compared to the 50-day average of 10.8 million.

Data source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

June 24, 2025 16:34 ET (20:34 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10